T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers
Clinical trial NCT02280811 · COMPLETED
Trial details
- NCT number
- NCT02280811
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-14
- Primary completion
- 2016-06-28
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.